350 related articles for article (PubMed ID: 38318147)
1. Modulation of the vitamin D receptor by traditional Chinese medicines and bioactive compounds: potential therapeutic applications in VDR-dependent diseases.
Yao M; Oduro PK; Akintibu AM; Yan H
Front Pharmacol; 2024; 15():1298181. PubMed ID: 38318147
[TBL] [Abstract][Full Text] [Related]
2. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K
Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor as a drug discovery target.
Pinette KV; Yee YK; Amegadzie BY; Nagpal S
Mini Rev Med Chem; 2003 May; 3(3):193-204. PubMed ID: 12570835
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view.
Carlberg C; Molnár F
Can J Physiol Pharmacol; 2015 May; 93(5):311-8. PubMed ID: 25741777
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor 2016: novel ligands and structural insights.
Maestro MA; Molnár F; Mouriño A; Carlberg C
Expert Opin Ther Pat; 2016 Nov; 26(11):1291-1306. PubMed ID: 27454349
[TBL] [Abstract][Full Text] [Related]
6. Structural Studies of Vitamin D Nuclear Receptor Ligand-Binding Properties.
Belorusova AY; Rochel N
Vitam Horm; 2016; 100():83-116. PubMed ID: 26827949
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor as a therapeutic target for benign prostatic hyperplasia.
Manchanda PK; Kibler AJ; Zhang M; Ravi J; Bid HK
Indian J Urol; 2012 Oct; 28(4):377-81. PubMed ID: 23450267
[TBL] [Abstract][Full Text] [Related]
8. Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways.
Chang PL; Lee TF; Garretson K; Prince CW
Clin Exp Metastasis; 1997 Nov; 15(6):580-92. PubMed ID: 9344042
[TBL] [Abstract][Full Text] [Related]
9. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
Wietzke JA; Welsh J
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
12. Syntheses of 25-Adamantyl-25-alkyl-2-methylidene-1α,25-dihydroxyvitamin D
Maekawa K; Ishizawa M; Ikawa T; Sajiki H; Matsumoto T; Tokiwa H; Makishima M; Yamada S
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509118
[TBL] [Abstract][Full Text] [Related]
13. Ancient Nuclear Receptor VDR With New Functions: Microbiome and Inflammation.
Bakke D; Sun J
Inflamm Bowel Dis; 2018 May; 24(6):1149-1154. PubMed ID: 29718408
[TBL] [Abstract][Full Text] [Related]
14. Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases.
Vertino AM; Bula CM; Chen JR; Almeida M; Han L; Bellido T; Kousteni S; Norman AW; Manolagas SC
J Biol Chem; 2005 Apr; 280(14):14130-7. PubMed ID: 15671029
[TBL] [Abstract][Full Text] [Related]
15. Development of vitamin D analogs modulating the pocket structure of vitamin D receptor.
Yamamoto K; Anami Y; Itoh T
Curr Top Med Chem; 2014; 14(21):2378-87. PubMed ID: 25537068
[TBL] [Abstract][Full Text] [Related]
16. The phenotype and function of murine bone marrow-derived dendritic cells is not affected by the absence of VDR or its ability to bind 1α,25-dihydroxyvitamin D
Vanherwegen AS; Ferreira GB; Smeets E; Yamamoto Y; Kato S; Overbergh L; Gysemans C; Mathieu C
J Steroid Biochem Mol Biol; 2016 Nov; 164():239-245. PubMed ID: 26343449
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor ligands: the impact of crystal structures.
Carlberg C; Molnár F; Mouriño A
Expert Opin Ther Pat; 2012 Apr; 22(4):417-35. PubMed ID: 22449247
[TBL] [Abstract][Full Text] [Related]
18. Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands.
Carlberg C
Recent Results Cancer Res; 2003; 164():29-42. PubMed ID: 12899512
[TBL] [Abstract][Full Text] [Related]
19. 1,25-Dihydroxyvitamin D
Li M; Li L; Zhang L; Hu W; Shen J; Xiao Z; Wu X; Chan FL; Cho CH
Life Sci; 2017 Jun; 179():88-97. PubMed ID: 28465245
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological studies of the A-ring-modified 1,25-dihydroxyvitamin D3 analogs.
Takayama H; Kittaka A; Fujishima T; Suhara Y
Recent Results Cancer Res; 2003; 164():289-317. PubMed ID: 12899530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
